KRT5 and breast cancer: Relative to Lenti-GFP infected cells, analysis of the BC marker KRT5 revealed no significant difference in expression in cells infected with Lenti-NICD1 (p>0.2), but a significant decrease in expression in cells infected with Lenti-NICD2, NICD3 or NICD4 (all p<0.02).